BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Lakewood-Amedex Inc. Elects Stephen Evans-Freke as New Chairman of the Board of Directors

  Mr. Evans-Freke is Co-Founder and Managing General Partner of Auven Therapeutics

  May 11, 2018

   · 

  2 min read
• Biotech Bay

  Genome Surgery for Eye Disease Moves Closer to Reality

  Study published in the journal of the American Academy of Ophthalmology shows that a CRISPR-based treatment can restore retinal function in mice

  May 11, 2018

   · 

  5 min read
• Policy

  Accreditation Council for Medical Affairs Calls for Credentialing Pharma Sales Reps & Medical Staff to Combat Opioid Crisis

  New Jersey & Florida Officials Express Their Support

  May 11, 2018

   · 

  2 min read
• Pharm Country

  Vesper Medical Completes $10.5 M Series A Financing to Drive Development of Next Generation Venous Stents

  Major participants in the Series A financing included New Enterprise Associates and Quaker Partners.

  May 11, 2018

   · 

  3 min read
• Biotech Beach

  Synthetic Genomics to Present at Upcoming Investor Conferences

  Oliver Fetzer, Ph.D., MBA, Chief Executive Officer, will present at the upcoming Bank of America Merrill Lynch 2018 Healthcare Conference and the Jefferies 2018 Global Healthcare Conference.

  May 11, 2018

   · 

  2 min read
• Business

  Eiger BioPharmaceuticals Reports First Quarter 2018 Financial Results

  Hepatitis Delta Virus (HDV) Program Moving into Phase 3

  May 11, 2018

   · 

  8 min read
• Business

  Cerus Endovascular Promotes Stephen Griffin, PhD, to President

  Company On-Track to Achieve Key Clinical and Regulatory Milestones

  May 11, 2018

   · 

  3 min read
• Business

  BioCardia, Inc. Reports First Quarter 2018 Financial Results And Business Highlights

  BioCardia reported a net loss of $3.6 million for the first quarter of 2018, which compares to a net loss of $2.9 million for the first quarter of 2017.

  May 11, 2018

   · 

  9 min read
• Pharm Country

  Northwell Health, Center on Addiction launch app to help providers screen for substance use

  Substance use disorder, including opioid dependency and addiction, is one of the gravest public health threats facing the United States.

  May 11, 2018

   · 

  4 min read
• Business

  Novus Therapeutics Reports First Quarter 2018 Financial Results

  Novus is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat

  May 11, 2018

   · 

  6 min read